Dr. Woodman is an endocrinologist who cares for individuals with endocrine disorders. He has a clinical interest in gonadal dysfunction, andrology, LGBT+ care, bone/calcium disorders, and obesity and metabolic health.
Dr. Woodman's research focuses on understanding how environmental and genetic influences affect diseases. Specifically, examining the contribution of alpha-2 adrenergic receptor signaling to the deleterious metabolic, gonadal, and behavioral effects found in stressed states, such as post-traumatic stress disorder and traumatic brain injury. He also has an interest in human performance and translation research.
Endocrinology, Diabetes, and Metabolism
D.O., Kansas City University, Kansas City MO 2012
B.S., UC San Diego, San Diego CA 2005
Internship: Internal Medicine, University of Missouri School of Medicine, Columbia MO 2012-2013
Internal Medicine, University of Missouri School of Medicine, Columbia MO 2013-2015
Endocrinology, University of Missouri School of Medicine, Columbia MO 2016-2018
American Board of Internal Medicine,
American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism,
Honors and Awards
Basic Science Research Award, Kansas City University, 2012
Select Recent Publications
Woodman R, Student J, Miller C, Lockette W. Ivabradine reduces adverse cognitive and behavioral responses following traumatic stress. Submitted, 2019
Woodman R, Student J, Malcolm T, Lockette W. Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: a treatment for emotional eating? Submitted, 2019
Woodman R, Brown C, Lockette W. Chlorthalidone decreases platelet aggregation and vascular permeability and promotes angiogenesis. Hypertension. 2010;56(3):463-470.
Watson R, Woodman R, Lockette W. Ephedra alkaloids inhibit platelet aggregation. Blood Coagul Fibrinolysis. 2010;21(3):266-271.
Woodman R, Lockette W. Alpha-methyltyrosine inhibits formation of reactive oxygen species and diminishes apoptosis in PC12 cells. Brain Res. 2009;1296:137-147.